Caution against Overinterpreting Time-Restricted Eating Results

TY - JOUR

T1 - Caution against Overinterpreting Time-Restricted Eating Results

AU - Agarwal, Dipti

AU - Chandra, Subhash

N1 - Funding Information: Funding/Support: This analysis was funded by an award (R01 HD095661) from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). Support for the HER Salt Lake Contraceptive Initiative comes from The Society of Family Planning Research Fund, the William and Flora Hewlett Foundation, and a large, anonymous family foundation. The following companies contributed contraceptive products: Bayer Women’s Healthcare, Merck & Co Inc, and Teva Pharmaceuticals. The authors also acknowledge support from two NICHD infrastructure grants (P2C HD047873 for the University of Wisconsin; the Building Interdisciplinary Researchers in Women’s Health K12 HD085852 for the University of Utah). Study data were collected and managed using REDCap (Research Electronic Data Capture) hosted at the University of Utah; this service is supported by Center for Clinical and Translational Sciences grant 8UL1TR000105. Dr Turok is funded by an NICHD Midcareer Investigator Award (K24 HD087436). Funding Information: Conflict of Interest Disclosures: Dr Tinsley has served as a scientific consultant for a phone application that allows users to monitor their usage of intermittent fasting programs; this consultancy consisted of providing evidence-based information regarding intermittent fasting. Dr Horne is the principal investigator of research grants for studies of intermittent fasting from the Intermountain Research and Medical Foundation. Funding Information: Author Contributions: All authors had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. Concept and design: Higgins, Turok, Sanders. Acquisition, analysis, or interpretation of data: All authors. Drafting of the manuscript: Higgins, Wright. Critical revision of the manuscript for important intellectual content: Higgins, Kramer, Everett, Turok, Sanders. Statistical analysis: Higgins, Kramer, Wright, Everett. Obtained funding: Higgins, Turok, Sanders. Administrative, technical, or material support: Higgins, Turok, Sanders. Supervision: Higgins, Turok, Sanders. Conflict of Interest Disclosures: Dr Higgins reported grants from Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (R01 HD095661) and grants from Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (Population Research Infrastructure Grant (P2C HD047873) during the conduct of the study. Dr Kramer and Ms Wright also receive support from, NICHD grant (P2C HD047873. Dr Turok reported grants from Eunice Kennedy Shriver National Institute of Child Health & Human Development Award number K24HD087436, nonfinancial support from Bayer pharmaceuticals They provided contraceptive devices for the study, nonfinancial support from Merck (they provided contraceptive devices for the study); nonfinancial support from Teva Pharmaceuticals (now Copper Surgical, they provided contraceptive devices for the study); grants from Anonymous Foundation, and grants from William and Flora Hewlett Foundation during the conduct of the study; fees from Sebela Pharmaceuticals The University of Utah Department of Obstetrics & Gynecology as a scientific advisor, fees from Medicines360. The University of Utah Department of Obstetrics & Gynecology has a contract to serve as a clinical research site used in this study. He also reports fees from Merck for the University of Utah Department of Obstetrics & Gynecology to conduct investigator-initiated research of the etonogestrel contraceptive implant outside the submitted work. Dr Sanders reported grants from NICHD R01 HD095661 and grants from NICHD K12 HD085852 during the conduct of the study. No other disclosures were reported.

PY - 2021/6

Y1 - 2021/6

UR - http://www.scopus.com/inward/record.url?scp=85101197203&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85101197203&partnerID=8YFLogxK

U2 - 10.1001/jamainternmed.2020.8931

DO - 10.1001/jamainternmed.2020.8931

M3 - Letter

C2 - 33616602

AN - SCOPUS:85101197203

SN - 2168-6106

VL - 181

SP - 876

EP - 877

JO - Archives of internal medicine (Chicago, Ill. : 1908)

JF - Archives of internal medicine (Chicago, Ill. : 1908)

IS - 6

ER -